首页 > 最新文献

Ancient Science of Life最新文献

英文 中文
Management of cholelithiasis (Gall Bladder Stone) through virecana (Therapeutic Purgation): A case study 韦乐纳治疗胆结石(胆囊结石)的个案研究
Pub Date : 2018-04-01 DOI: 10.4103/asl.ASL_113_17
Shital Bhagiya, T. Kumar, N. Bhatt, B. Thakar
Gall bladder (GB) is an important organ under the biliary system. Cholelithiasis (gall stones) is one of the most common among all conditions affecting GB. Surgery (cholecystectomy) is the most common form of treatment for cholelithiasis. Surgically removing of cholelithiasis requires the removal of an entire organ. After the removal of GB, the patient becomes away from the normal physiological life and feels abdominal discomfort with indigestion. This has led to a growing interest in nonsurgical treatments for cholelithiasis. In the present case, the patient was suffering with abdominal pain, nausea, loos stool after every meal. The patient was given systemic virecana and after that medicine was given for 3 months and all symptoms with GB stone were disappeared. In Ayurveda, taking an idea from aśmari (Calculi), one can frame its pathology like in cholelithiasis excessive kapha reaches at pittāśaya (GB) and solidifies there with rūkṣa guṇa (dry property) of vāta to turns into stone form. virecana (therapeutic purgation) is the best treatment for this, as the site is pittāśaya. virecana is indicated for all doṣa. Efficacy of virecana karma in reference to the management of GB stone has not been well documented till date. Hence, an attempt has been made to see the efficacy of virecana karma in cholelithiasis.
胆囊(GB)是胆道系统的重要器官。胆石症(胆结石)是影响GB的所有疾病中最常见的一种。手术(胆囊切除术)是胆石症最常见的治疗形式。手术切除胆石症需要切除整个器官。切除GB后,患者脱离正常生理生活,腹部不适,消化不良。这使得人们对非手术治疗胆石症的兴趣日益浓厚。在本病例中,患者每餐后腹痛,恶心,便便。患者全身给予维瑞卡纳,用药3个月后,结石症状全部消失。在阿育吠陀中,从aśmari(结石)中获得一个想法,人们可以将其病理学描述为胆石症,过量的卡法到达pittāśaya (GB),并在那里与vāta的rūkṣa guṇa(干燥性)凝固,变成石头形式。Virecana(治疗性净化)是最好的治疗方法,治疗地点是pittāśaya。维瑞卡纳适用于所有doṣa。到目前为止,维里卡纳业力在GB石管理方面的功效还没有得到很好的记录。因此,有人尝试观察维里卡纳业力对胆石症的疗效。
{"title":"Management of cholelithiasis (Gall Bladder Stone) through virecana (Therapeutic Purgation): A case study","authors":"Shital Bhagiya, T. Kumar, N. Bhatt, B. Thakar","doi":"10.4103/asl.ASL_113_17","DOIUrl":"https://doi.org/10.4103/asl.ASL_113_17","url":null,"abstract":"Gall bladder (GB) is an important organ under the biliary system. Cholelithiasis (gall stones) is one of the most common among all conditions affecting GB. Surgery (cholecystectomy) is the most common form of treatment for cholelithiasis. Surgically removing of cholelithiasis requires the removal of an entire organ. After the removal of GB, the patient becomes away from the normal physiological life and feels abdominal discomfort with indigestion. This has led to a growing interest in nonsurgical treatments for cholelithiasis. In the present case, the patient was suffering with abdominal pain, nausea, loos stool after every meal. The patient was given systemic virecana and after that medicine was given for 3 months and all symptoms with GB stone were disappeared. In Ayurveda, taking an idea from aśmari (Calculi), one can frame its pathology like in cholelithiasis excessive kapha reaches at pittāśaya (GB) and solidifies there with rūkṣa guṇa (dry property) of vāta to turns into stone form. virecana (therapeutic purgation) is the best treatment for this, as the site is pittāśaya. virecana is indicated for all doṣa. Efficacy of virecana karma in reference to the management of GB stone has not been well documented till date. Hence, an attempt has been made to see the efficacy of virecana karma in cholelithiasis.","PeriodicalId":7805,"journal":{"name":"Ancient Science of Life","volume":"38 1","pages":"73 - 76"},"PeriodicalIF":0.0,"publicationDate":"2018-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43193327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Jalaukāvacaraṇa (Hirudo therapy) in the management of necrosed index finger due to crush injury Jalaukāvacaraṇa(喜疗妥疗法)治疗因挤压伤坏死的食指
Pub Date : 2018-04-01 DOI: 10.4103/asl.ASL_163_16
D. Sambhaji, Komang Sudarmi
Necrosis of tissue has become the challenging case, considering the difficulties of its management to bring back the normalcy of dead tissue. Treatment choice in surgery ends up with amputation of the affected part which leads to depression to a patient. In Ayurveda, posttraumatic necrosis can be correlated with picchita vraṇa (crushed injury) which is included under āgantuja vraṇa (traumatic injury). In this case report, an interesting case of posttraumatic necrotic changes of the right index finger was presented to us at the Outpatient Department of Ayurved Research Hospital. There was symptom of aggravated pain along with gradual discoloration of the tip of the index finger to a necrotic condition. Naturally, such cases have a very poor prognosis. Considering the pathological changes in this case, jalaukāvacaraṇa (Hirudo therapy) procedure has been taken up for the management. In the 1st week, three leeches were applied after every 3 days, and later on, after every 7 days, further three sittings of leech application were done. Leech absorbed impure blood which results in neovascularization and reconstruction of the necrotic tissue. Antiplatelet and antithrombin action of hirudin present in saliva of leech recanalizes the thrombus or clot at the injured part. The patient was cured completely and survived the finger from amputation with jalaukāvacaraṇa (Hirudo therapy).
考虑到恢复死亡组织正常的管理困难,组织坏死已成为一个具有挑战性的案例。手术中的治疗选择最终会导致患者患部截肢,从而导致抑郁。在阿育吠陀中,创伤后坏死可与皮奇托vra相关ṇa(挤压伤),包括在āgantuja vra下ṇa(创伤性损伤)。在本病例报告中,阿育吠陀研究医院门诊部向我们介绍了一个有趣的右食指创伤后坏死变化病例。伴随着食指指尖逐渐变色坏死,出现了疼痛加剧的症状。当然,这类病例的预后非常差。考虑到本例的病理变化,jalaukāvacaraṇ已经采用了(喜疗妥疗法)程序进行管理。在第1周,每3天施用三次水蛭,随后,每7天再施用三次。水蛭吸收了不纯净的血液,导致坏死组织的新生血管形成和重建。水蛭唾液中水蛭素的抗血小板和抗凝血酶作用可使受伤部位的血栓或凝块再通。患者完全治愈,并用jalaukāvacara从截肢手术中幸存下来ṇa(喜疗妥疗法)。
{"title":"Jalaukāvacaraṇa (Hirudo therapy) in the management of necrosed index finger due to crush injury","authors":"D. Sambhaji, Komang Sudarmi","doi":"10.4103/asl.ASL_163_16","DOIUrl":"https://doi.org/10.4103/asl.ASL_163_16","url":null,"abstract":"Necrosis of tissue has become the challenging case, considering the difficulties of its management to bring back the normalcy of dead tissue. Treatment choice in surgery ends up with amputation of the affected part which leads to depression to a patient. In Ayurveda, posttraumatic necrosis can be correlated with picchita vraṇa (crushed injury) which is included under āgantuja vraṇa (traumatic injury). In this case report, an interesting case of posttraumatic necrotic changes of the right index finger was presented to us at the Outpatient Department of Ayurved Research Hospital. There was symptom of aggravated pain along with gradual discoloration of the tip of the index finger to a necrotic condition. Naturally, such cases have a very poor prognosis. Considering the pathological changes in this case, jalaukāvacaraṇa (Hirudo therapy) procedure has been taken up for the management. In the 1st week, three leeches were applied after every 3 days, and later on, after every 7 days, further three sittings of leech application were done. Leech absorbed impure blood which results in neovascularization and reconstruction of the necrotic tissue. Antiplatelet and antithrombin action of hirudin present in saliva of leech recanalizes the thrombus or clot at the injured part. The patient was cured completely and survived the finger from amputation with jalaukāvacaraṇa (Hirudo therapy).","PeriodicalId":7805,"journal":{"name":"Ancient Science of Life","volume":"38 1","pages":"68 - 72"},"PeriodicalIF":0.0,"publicationDate":"2018-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47347697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concept of Kushta (calx) and studies carried out on Kushta in unani medicine Kushta(calx)的概念与乌南医学对Kushta的研究
Pub Date : 2018-04-01 DOI: 10.4103/asl.ASL_93_19
Haqeeq Ahmad, A. Wadud, G. Sofi, N. Jahan, Hamiduddin
Objective: Kushta (calx) is a well-known dosage form of Unani medicine but has always been condemned by scientific fraternity and even some traditionalists because of certain issues associated with Kushta such as safety, lack of scientific data, adverse effects, and complicated method of preparation. Very few studies are carried out on Kushta in Unani medicine and no study has explored its mechanism of action on scientific basis that may be acceptable widely. Methodology: In this study, the review was done regarding the concept of Kushta in Unani medicine, and studies carried out so far along with a possible explanation of the effectiveness, classical method of preparation, superiority of Kushta over other dosage forms, challenges with use of Kushta, idea of use of herbs in making Kushta, and other issues. Literature on Kushta was collected from classical Unani books and papers published in various journals and analyzed. We found that very few scientific studies have been carried out on Kushta in Unani medicine and that too on certain set topics. Most studies are on physicochemical standardization of Kushta. Conclusion: Study revealed that the research carried out so far is not satisfactory. They are also of preliminary nature. Advance toxicological and pharmacological studies are required to generate strong evidences for wide acceptability, safety, and efficacy of Kushta.
目的:库什塔(calx)是一种众所周知的乌纳尼药物剂型,但由于库什塔的安全性、缺乏科学数据、不良反应和制备方法复杂等问题,一直受到科学界甚至一些传统主义者的谴责。在乌纳尼医学中对库什塔进行的研究很少,也没有研究在科学基础上探索其可被广泛接受的作用机制。方法:在这项研究中,对库什塔在乌纳尼医学中的概念进行了回顾,到目前为止进行的研究以及对库什塔有效性的可能解释,经典的制备方法,库什塔比其他剂型的优越性,使用库什塔的挑战,在制作库什塔时使用草药的想法,以及其他问题。关于库什塔的文献是从经典的乌纳尼书籍和发表在各种期刊上的论文中收集和分析的。我们发现,在乌纳尼医学中,很少有关于库什塔的科学研究,在某些特定的主题上也是如此。大多数研究都是关于库什塔的理化标准化。结论:研究表明,目前开展的研究并不令人满意。它们也具有初步的性质。需要提前进行毒理学和药理学研究,以提供强有力的证据来证明库什塔的广泛可接受性、安全性和有效性。
{"title":"Concept of Kushta (calx) and studies carried out on Kushta in unani medicine","authors":"Haqeeq Ahmad, A. Wadud, G. Sofi, N. Jahan, Hamiduddin","doi":"10.4103/asl.ASL_93_19","DOIUrl":"https://doi.org/10.4103/asl.ASL_93_19","url":null,"abstract":"Objective: Kushta (calx) is a well-known dosage form of Unani medicine but has always been condemned by scientific fraternity and even some traditionalists because of certain issues associated with Kushta such as safety, lack of scientific data, adverse effects, and complicated method of preparation. Very few studies are carried out on Kushta in Unani medicine and no study has explored its mechanism of action on scientific basis that may be acceptable widely. Methodology: In this study, the review was done regarding the concept of Kushta in Unani medicine, and studies carried out so far along with a possible explanation of the effectiveness, classical method of preparation, superiority of Kushta over other dosage forms, challenges with use of Kushta, idea of use of herbs in making Kushta, and other issues. Literature on Kushta was collected from classical Unani books and papers published in various journals and analyzed. We found that very few scientific studies have been carried out on Kushta in Unani medicine and that too on certain set topics. Most studies are on physicochemical standardization of Kushta. Conclusion: Study revealed that the research carried out so far is not satisfactory. They are also of preliminary nature. Advance toxicological and pharmacological studies are required to generate strong evidences for wide acceptability, safety, and efficacy of Kushta.","PeriodicalId":7805,"journal":{"name":"Ancient Science of Life","volume":"38 1","pages":"37 - 44"},"PeriodicalIF":0.0,"publicationDate":"2018-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46805427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methanolic extract of Jasminum humile L. leaves possess anxiolytic activity mediated via the gabaergic system in the central nervous system of mice 茉莉叶的甲醇提取物具有通过小鼠中枢神经系统的GABA能系统介导的抗焦虑活性
Pub Date : 2018-04-01 DOI: 10.4103/asl.ASL_37_20
Parminder Nain, M. Bhatia, Jaspreet Kaur
Background: Jasminum humile L. is one of the traditional medicinal plants from Oleaceae family. It is abundantly available in Afghanistan, Pakistan, Nepal, Burma, the Himalayas, and southwest China. The tea of leaves and barks are used conventionally in the treatment of various diseases such as central nervous system disorder, anti-inflammatory, and antiseptic. Aim: The present study was undertaken to investigate the anxiolytic effect of methanolic extract of J. humile L. leaves (MEJHL). Materials and Methods: Anxiolytic activity of J. humile L. leaves extracts were evaluated using Elevated Plus-Maze (EPM) and light/dark exploration models. The motor coordination and sedative effect were also observed using Rota Rod apparatus, actophotometer, and ketamine-induced sleeping time, respectively. Brain neurotransmitters like GABA level were estimated by validated methods. Results: From the acute toxicity studies, extracts of J. humile L. leaves were found to be nontoxic. Among all extracts, the only methanolic extract showed significant (P < 0.05) anxiolytic activity. Preliminary phytochemical screening revealed the presence of carbohydrates, flavonoids, and alkaloids in the MEJHL. The results of anxiolytic models clearly depicted that MEJHL at the dose of 200 mg/kg significantly (P < 0.05) increased the number of entries and the average time spent in the open arms and light compartment of the EPM and light/dark models, respectively. In the case of motor coordination activity, the MEJHL does not cause any significant effect (at any dose) on the latency to fall off from the Rota Rod bar compared to the control group. Moreover, no remarkable effects in actophotometer and on ketamine-induced sleep latency and total sleeping time induced by ketamine was observed. Results of neurotransmitter estimation in the whole brain and the cerebellum revealed the increased concentration of GABA was similar to standard drug diazepam. Conclusions: The presence of alkaloids in the methanolic extract of this plant can serve as a potential resource for natural psychotherapeutic agents against anxiety with less sedation.
背景:胡茉莉是木犀科传统药用植物之一。它在阿富汗、巴基斯坦、尼泊尔、缅甸、喜马拉雅山和中国西南部随处可见。茶叶和树皮通常用于治疗各种疾病,如中枢神经系统疾病、抗炎症和防腐剂。目的:研究胡麻叶甲醇提取物(MEJHL)的抗焦虑作用。材料和方法:采用Elevated Plus Maze(EPM)和光/暗探索模型评价胡麻叶提取物的解焦虑活性。使用Rota-Rod装置、动力计和氯胺酮诱导的睡眠时间分别观察运动协调和镇静效果。大脑神经递质如GABA水平通过验证的方法估计。结果:从急性毒性研究中发现,胡麻叶提取物是无毒的。在所有提取物中,只有甲醇提取物表现出显著的抗焦虑活性(P<0.05)。初步的植物化学筛选揭示了MEJHL中存在碳水化合物、黄酮类化合物和生物碱。抗焦虑模型的结果清楚地表明,200mg/kg剂量的MEJHL分别显著增加了进入EPM和亮/暗模型的开放臂和亮区的次数和平均时间(P<0.05)。在运动协调活动的情况下,与对照组相比,MEJHL对Rota棒脱落的潜伏期没有任何显著影响(在任何剂量下)。此外,在动作光度计和氯胺酮诱导的睡眠潜伏期和总睡眠时间方面没有观察到显著的影响。整个大脑和小脑的神经递质估计结果显示,GABA浓度的增加与标准药物地西泮相似。结论:该植物甲醇提取物中存在生物碱,可作为一种潜在的天然抗焦虑药物来源,镇静效果较差。
{"title":"Methanolic extract of Jasminum humile L. leaves possess anxiolytic activity mediated via the gabaergic system in the central nervous system of mice","authors":"Parminder Nain, M. Bhatia, Jaspreet Kaur","doi":"10.4103/asl.ASL_37_20","DOIUrl":"https://doi.org/10.4103/asl.ASL_37_20","url":null,"abstract":"Background: Jasminum humile L. is one of the traditional medicinal plants from Oleaceae family. It is abundantly available in Afghanistan, Pakistan, Nepal, Burma, the Himalayas, and southwest China. The tea of leaves and barks are used conventionally in the treatment of various diseases such as central nervous system disorder, anti-inflammatory, and antiseptic. Aim: The present study was undertaken to investigate the anxiolytic effect of methanolic extract of J. humile L. leaves (MEJHL). Materials and Methods: Anxiolytic activity of J. humile L. leaves extracts were evaluated using Elevated Plus-Maze (EPM) and light/dark exploration models. The motor coordination and sedative effect were also observed using Rota Rod apparatus, actophotometer, and ketamine-induced sleeping time, respectively. Brain neurotransmitters like GABA level were estimated by validated methods. Results: From the acute toxicity studies, extracts of J. humile L. leaves were found to be nontoxic. Among all extracts, the only methanolic extract showed significant (P < 0.05) anxiolytic activity. Preliminary phytochemical screening revealed the presence of carbohydrates, flavonoids, and alkaloids in the MEJHL. The results of anxiolytic models clearly depicted that MEJHL at the dose of 200 mg/kg significantly (P < 0.05) increased the number of entries and the average time spent in the open arms and light compartment of the EPM and light/dark models, respectively. In the case of motor coordination activity, the MEJHL does not cause any significant effect (at any dose) on the latency to fall off from the Rota Rod bar compared to the control group. Moreover, no remarkable effects in actophotometer and on ketamine-induced sleep latency and total sleeping time induced by ketamine was observed. Results of neurotransmitter estimation in the whole brain and the cerebellum revealed the increased concentration of GABA was similar to standard drug diazepam. Conclusions: The presence of alkaloids in the methanolic extract of this plant can serve as a potential resource for natural psychotherapeutic agents against anxiety with less sedation.","PeriodicalId":7805,"journal":{"name":"Ancient Science of Life","volume":"38 1","pages":"45 - 52"},"PeriodicalIF":0.0,"publicationDate":"2018-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44884482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An ayurvedic management of chronic nonhealing ulcer in buerger's disease w.s.r. to gambhīra vātarakta: A case study 阿育吠陀治疗buerger病的慢性不愈合溃疡w.s.r.to gambhīra vātarakta:一个案例研究
Pub Date : 2018-04-01 DOI: 10.4103/asl.ASL_134_17
Santosh Mudakappagol, A. Wali, H. Salma, Ramesh S. Killedar
Buerger's disease is associated with ulcers in the extremities with the possibility of amputation. The prevalence of the disease among all patients with peripheral arterial disease ranged 5%–10%. Heavy cigarette smoking has been implicated the main etiology and only treatment that has been shown to be effective is complete abstention from smoking. In spite of this, the disease progresses in up to 30% of cases and finally results in limb amputation. Here, it is a case report of a 45-year-old male patient who came with complaints of severe pain and nonhealing arterial ulcer over the right great toe for 3 months with a diagnosis of Buerger's disease. The present case scenario is clinically correlated to gambhīra vātarakta, owing to the mārgāvaraṇa (obstruction) pathology and managed effectively with mañjiṣṭhādi kṣārabasti (Medicated enema), raktamokṣaṇa (bloodletting), and śamana auṣadhi (oral medications) which hoarded him from amputation.
伯格氏病与可能截肢的四肢溃疡有关。该疾病在所有外周动脉疾病患者中的患病率在5%-10%之间。重度吸烟被认为是主要病因,唯一被证明有效的治疗方法是完全戒烟。尽管如此,这种疾病在高达30%的病例中发展,最终导致截肢。这是一例45岁男性患者的病例报告,他主诉右大脚趾剧烈疼痛和动脉溃疡持续3个月,诊断为Buerger病。由于mārgāvaraṇa(梗阻)病理学,目前的病例场景在临床上与gambhīra vātarakta相关,并通过mañjiṣṣārabasti(药物灌肠),raktamokṣ一ṇa(放血)和śamana aus adhi(口服药物)使他免于截肢。
{"title":"An ayurvedic management of chronic nonhealing ulcer in buerger's disease w.s.r. to gambhīra vātarakta: A case study","authors":"Santosh Mudakappagol, A. Wali, H. Salma, Ramesh S. Killedar","doi":"10.4103/asl.ASL_134_17","DOIUrl":"https://doi.org/10.4103/asl.ASL_134_17","url":null,"abstract":"Buerger's disease is associated with ulcers in the extremities with the possibility of amputation. The prevalence of the disease among all patients with peripheral arterial disease ranged 5%–10%. Heavy cigarette smoking has been implicated the main etiology and only treatment that has been shown to be effective is complete abstention from smoking. In spite of this, the disease progresses in up to 30% of cases and finally results in limb amputation. Here, it is a case report of a 45-year-old male patient who came with complaints of severe pain and nonhealing arterial ulcer over the right great toe for 3 months with a diagnosis of Buerger's disease. The present case scenario is clinically correlated to gambhīra vātarakta, owing to the mārgāvaraṇa (obstruction) pathology and managed effectively with mañjiṣṭhādi kṣārabasti (Medicated enema), raktamokṣaṇa (bloodletting), and śamana auṣadhi (oral medications) which hoarded him from amputation.","PeriodicalId":7805,"journal":{"name":"Ancient Science of Life","volume":"38 1","pages":"77 - 81"},"PeriodicalIF":0.0,"publicationDate":"2018-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48551389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SAMANVAYA 2018: Conference on integrative diabetology – Present trends in diabetes care SAMANVAYA 2018:综合糖尿病会议-糖尿病护理的当前趋势
Pub Date : 2018-01-01 DOI: 10.4103/asl.asl_11_19
D. Patil, N. Patil, L. Sunitha
{"title":"SAMANVAYA 2018: Conference on integrative diabetology – Present trends in diabetes care","authors":"D. Patil, N. Patil, L. Sunitha","doi":"10.4103/asl.asl_11_19","DOIUrl":"https://doi.org/10.4103/asl.asl_11_19","url":null,"abstract":"","PeriodicalId":7805,"journal":{"name":"Ancient Science of Life","volume":"38 1","pages":"32 - 33"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42098523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayurvedic management of lumbar disc disease - A case report 阿育吠陀治疗腰椎间盘疾病1例报告
Pub Date : 2018-01-01 DOI: 10.4103/asl.asl_197_17
Vaidya Pandey, N. Kaushik
Lumbar disc disease (LDD) is a common cause of chronic or recurrent low back and leg pain most likely to occur at the L4-L5 and L5-S1 levels. The pain may be located in the lower back only or may refer to the leg, buttocks, or hip. There is less improvement with modern medicines and recurrence due to surgical decompression. Various Ayurvedic drugs along with required pañcakarma procedures have been proved useful for these manifestations. We present a case of LDD (kaṭi asthi sandhi gata vᾱta) having acute severe lower back pain above left hip joint radiating towards the left thigh and calf muscle since 14 days. His visual analog scale (VAS) score was 10 when he arrived at the hospital. The case was treated for 3 months with a combination of ᾱyurvedic drugs and pañcakarma procedures. Ayurvedic treatments, in this case, were directed toward alleviating pain and to reduce disability to walk. The patient was considered suffering from kaṭi asthi sandhi gata vᾱta (vᾱtaj disorder involving lumbar region) and was given harītakī cῡrṇa 5 g with lukewarm water on the first night for vᾱtᾱnulomana. ekāṅgavīra rasa, punarnavādi maṇḍūra, rᾱsnᾱsaptaka kvᾱtha, balāriṣṭa, ajamodādi cūrṇa, orally have been given with saindhavādi taila for local application for 3 months. For śodhana cikitsā sarvāṅga abhyaṅga and sarvāṅga patra piṇḍa svedana (PPS), kaṭi basti with pañcaguṇa taila and kᾱla basti (nirῡha with rᾱsnᾱ eraṇḍādi kvᾱtha and anuvᾱsana with dhānvantaraṃ taila) for 16 days is given. Patient's condition was assessed for symptoms of kaṭi asthi sandhi gata vᾱta and VAS scale for pain, Fukushima lumbar spinal stenosis scale-25, and 6 min walking test before and after the treatment which showed substantial improvement. This study shows that the cases of lumbar disc disease which may be successfully managed with ayurvedic treatment.
腰椎间盘疾病(LDD)是慢性或复发性腰背部和腿部疼痛的常见原因,最可能发生在L4-L5和L5-S1水平。疼痛可仅发生在下背部,也可累及腿部、臀部或臀部。现代药物治疗改善较少,手术减压后复发。各种阿育吠陀药物以及所需的pañcakarma程序已被证明对这些表现有用。我们报告一例LDD (kaṭi哮喘sandhi gata v□ta),左髋关节以上急性严重腰痛,向左大腿和小腿肌肉放射14天。当他到达医院时,他的视觉模拟评分(VAS)为10分。该病例接受了3个月的联合治疗,使用了育吠陀药物和pañcakarma程序。在这种情况下,阿育吠陀疗法的目的是减轻疼痛,减少行走障碍。患者考虑为kaṭi哮喘sandhi gata v□ta(累及腰部的v□taj紊乱),于首晚给予har taki ā c ā rṇa 5 g加温水治疗v□t□nulomana。Ekāṅgavīra rasa, punarnavādi maṇḍūra, r□sn□saptaka kv□tha, balāriṣṭa, ajamodādi cūrṇa,口服,配合saindhavādi taila局部应用3个月。对于śodhana cikitsza sarvāṅga abhyaṅga和sarvāṅga patra piṇḍa svedana (PPS),给予kaṭi basti with pañcaguṇa taila和k æ la basti (nir ha with r sn eraṇḍādi kv tha和anuv sana with dhānvantaraṃ taila) 16天。治疗前后对患者进行kaṭi哮喘病症状评估、疼痛VAS评分、福岛腰椎管狭窄量表-25分、6 min步行测试,均有明显改善。本研究表明,病例腰椎间盘疾病,这可能是成功的管理与阿育吠陀治疗。
{"title":"Ayurvedic management of lumbar disc disease - A case report","authors":"Vaidya Pandey, N. Kaushik","doi":"10.4103/asl.asl_197_17","DOIUrl":"https://doi.org/10.4103/asl.asl_197_17","url":null,"abstract":"Lumbar disc disease (LDD) is a common cause of chronic or recurrent low back and leg pain most likely to occur at the L4-L5 and L5-S1 levels. The pain may be located in the lower back only or may refer to the leg, buttocks, or hip. There is less improvement with modern medicines and recurrence due to surgical decompression. Various Ayurvedic drugs along with required pañcakarma procedures have been proved useful for these manifestations. We present a case of LDD (kaṭi asthi sandhi gata vᾱta) having acute severe lower back pain above left hip joint radiating towards the left thigh and calf muscle since 14 days. His visual analog scale (VAS) score was 10 when he arrived at the hospital. The case was treated for 3 months with a combination of ᾱyurvedic drugs and pañcakarma procedures. Ayurvedic treatments, in this case, were directed toward alleviating pain and to reduce disability to walk. The patient was considered suffering from kaṭi asthi sandhi gata vᾱta (vᾱtaj disorder involving lumbar region) and was given harītakī cῡrṇa 5 g with lukewarm water on the first night for vᾱtᾱnulomana. ekāṅgavīra rasa, punarnavādi maṇḍūra, rᾱsnᾱsaptaka kvᾱtha, balāriṣṭa, ajamodādi cūrṇa, orally have been given with saindhavādi taila for local application for 3 months. For śodhana cikitsā sarvāṅga abhyaṅga and sarvāṅga patra piṇḍa svedana (PPS), kaṭi basti with pañcaguṇa taila and kᾱla basti (nirῡha with rᾱsnᾱ eraṇḍādi kvᾱtha and anuvᾱsana with dhānvantaraṃ taila) for 16 days is given. Patient's condition was assessed for symptoms of kaṭi asthi sandhi gata vᾱta and VAS scale for pain, Fukushima lumbar spinal stenosis scale-25, and 6 min walking test before and after the treatment which showed substantial improvement. This study shows that the cases of lumbar disc disease which may be successfully managed with ayurvedic treatment.","PeriodicalId":7805,"journal":{"name":"Ancient Science of Life","volume":"38 1","pages":"26 - 31"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43818288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practice-based evidence in Ayurveda 阿育吠陀的实践证据
Pub Date : 2018-01-01 DOI: 10.4103/asl.asl_105_22
S. Eranezhath
{"title":"Practice-based evidence in Ayurveda","authors":"S. Eranezhath","doi":"10.4103/asl.asl_105_22","DOIUrl":"https://doi.org/10.4103/asl.asl_105_22","url":null,"abstract":"","PeriodicalId":7805,"journal":{"name":"Ancient Science of Life","volume":"38 1","pages":"1 - 2"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45563082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Acute oral toxicity evaluation of Hridayarnava Rasa (A Herbo-Mineral Ayurvedic Formulation) prepared from aśodhita and śodhita tāmra bhasma 从aśodhita和śodhita tāmra bhasma制备的Hridayarnava Rasa(草药矿物阿育吠陀配方)的急性口服毒性评价
Pub Date : 2018-01-01 DOI: 10.4103/asl.asl_14_18
C. Jagtap, M. Nariya, V. Shukla, P. Prajapati
Background: Herbo-mineral preparations used in Ayurveda are seen as a matter of concern nowadays; especially for containing metals such as mercury, lead, and copper. One of such formulations is hṛdayārṇava rasa (HR) which contains black sulfide of mercury and tāmra bhasma. Till date, no safety profile of this formulation is available. In the present study, acute oral toxicity of HR prepared from tāmra bhasma in aśodhita and śodhita form was evaluated to provide the safety profile on acute administration. Materials and Methods: HR prepared from śodhita tāmra bhasma (STBHR) and HR prepared from aśodhita tāmra bhasma (ATBHR) was prepared as per the classical reference. Acute toxicity test was evaluated as per OECD 425 guidelines with 2000 mg/kg as a limit test. Fifteen Wistar strain albino female rats (Rattus norvegicus) were randomly divided into three groups of five animals each. One group served as control, and other two served as experimental groups. Test formulation was administered orally to overnight fasted female rats, and detailed behavioral changes and mortality were recorded for 14 days. Parameters such as body weight, hematological and biochemical parameters, and histopathological study of some important organs were assessed. Results: No significant changes in behavior, mortality, body weight, and hematological parameters were observed in all the animals. Some biochemical parameters such as blood urea, alkaline phosphatase, serum glutamic oxaloacetic transaminase, and serum glutamic pyruvic transaminase were affected in both the test drugs. In histopathological study, sections of liver and kidney showed some degenerative changes; comparatively more in ATBHR. Conclusion: The results of the study demonstrate that LD50 of both the test drugs are higher than 2000 mg/kg. It was concluded that both the test drugs at higher dose levels can cause hepatorenal toxicity. However, further chronic toxicity evaluation is necessary to establish the safety profile on chronic administration.
背景:在阿育吠陀中使用的草药矿物制剂如今被视为一个令人担忧的问题;尤其是含有汞、铅和铜等金属的。其中一种配方是hṛdayārṇava rasa (HR),它含有汞的黑色硫化物和tāmra巴斯玛。到目前为止,还没有这种配方的安全性资料。在本研究中,我们对aśodhita和śodhita形式的tāmra巴斯马制备的HR进行了急性口服毒性评估,以提供急性给药的安全性。材料与方法:śodhita tāmra bhasma制备的HR (STBHR)和aśodhita tāmra bhasma制备的HR (ATBHR)参照经典文献制备。急性毒性试验按照OECD 425准则进行评估,限量试验为2000 mg/kg。选取褐家鼠Wistar系白化雌性大鼠15只,随机分为3组,每组5只。一组作为对照组,另外两组作为实验组。将试验配方口服禁食过夜的雌性大鼠,记录14天的详细行为变化和死亡率。评估体重、血液学和生化指标以及一些重要器官的组织病理学研究等参数。结果:所有动物的行为、死亡率、体重和血液学参数均无明显变化。两种药物对血尿素、碱性磷酸酶、血清谷草酰转氨酶、血清谷丙转氨酶等生化指标均有影响。组织病理学检查,肝、肾切片出现退行性改变;而在ATBHR中相对较多。结论:两种试验药物的LD50均大于2000 mg/kg。结果表明,两种试验药物在较高剂量下均可引起肝肾毒性。然而,需要进一步的慢性毒性评价来确定长期给药的安全性。
{"title":"Acute oral toxicity evaluation of Hridayarnava Rasa (A Herbo-Mineral Ayurvedic Formulation) prepared from aśodhita and śodhita tāmra bhasma","authors":"C. Jagtap, M. Nariya, V. Shukla, P. Prajapati","doi":"10.4103/asl.asl_14_18","DOIUrl":"https://doi.org/10.4103/asl.asl_14_18","url":null,"abstract":"Background: Herbo-mineral preparations used in Ayurveda are seen as a matter of concern nowadays; especially for containing metals such as mercury, lead, and copper. One of such formulations is hṛdayārṇava rasa (HR) which contains black sulfide of mercury and tāmra bhasma. Till date, no safety profile of this formulation is available. In the present study, acute oral toxicity of HR prepared from tāmra bhasma in aśodhita and śodhita form was evaluated to provide the safety profile on acute administration. Materials and Methods: HR prepared from śodhita tāmra bhasma (STBHR) and HR prepared from aśodhita tāmra bhasma (ATBHR) was prepared as per the classical reference. Acute toxicity test was evaluated as per OECD 425 guidelines with 2000 mg/kg as a limit test. Fifteen Wistar strain albino female rats (Rattus norvegicus) were randomly divided into three groups of five animals each. One group served as control, and other two served as experimental groups. Test formulation was administered orally to overnight fasted female rats, and detailed behavioral changes and mortality were recorded for 14 days. Parameters such as body weight, hematological and biochemical parameters, and histopathological study of some important organs were assessed. Results: No significant changes in behavior, mortality, body weight, and hematological parameters were observed in all the animals. Some biochemical parameters such as blood urea, alkaline phosphatase, serum glutamic oxaloacetic transaminase, and serum glutamic pyruvic transaminase were affected in both the test drugs. In histopathological study, sections of liver and kidney showed some degenerative changes; comparatively more in ATBHR. Conclusion: The results of the study demonstrate that LD50 of both the test drugs are higher than 2000 mg/kg. It was concluded that both the test drugs at higher dose levels can cause hepatorenal toxicity. However, further chronic toxicity evaluation is necessary to establish the safety profile on chronic administration.","PeriodicalId":7805,"journal":{"name":"Ancient Science of Life","volume":"38 1","pages":"3 - 11"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45196290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of śodhana śamana and bṛṃhaṇa basti in the Management of gṛdhrasī 347 odhanaśamana和b的作用ṛṃ哈ṇg管理的堡垒ṛdhrasī
Pub Date : 2018-01-01 DOI: 10.4103/asl.asl_213_16
Adil Rais, S. Tanwar, A. Thakar
gṛdhrasī is a common disorder explained in the context of vāta vyādhi in Ayurveda which greatly interferes with the quality of life. The symptoms of Gṛdhrasī simulate with sciatica. Sciatica is one of the most common causes of pain and disability. The treatment available in modern medicine for sciatica is either conservative such as rest, immobilization, analgesics, anti-inflammatory, or surgical which is not much satisfactory. Here, a case of 58-year-old female complaining of low backache radiating to the left lower limb along with numbness in the distal portion of the left leg and inability to walk without support, is reported. basti cikitsā (medicated enema) is the prime treatment modality among the pañcakarma (five main purifcation procedures) for vāta doṣa and śodhana therapy has already been established being better than śamana, a specific śodhana (purificatory), śamana (palliative) and bṛṃhaṇa (nourishing the tissues and producing anabolic effects) basti was planned in this particular case. The case under the study showed remarkable improvement in almost all the subjective and objective parameters within a span of 8 days of basti and after the follow-up of 1 month. śodhana, śamana, and bṛṃhaṇa Basti were satisfactory on subjective, objective as well as radiographic parameters and can be applied on cases of sciatica after consideration of the doṣas involved.
gṛdhrasī是一种常见的障碍,在阿育吠陀的vāta vyādhi语境中被解释为严重干扰生活质量。G的症状ṛdhrasī模拟坐骨神经痛。坐骨神经痛是导致疼痛和残疾的最常见原因之一。现代医学上对坐骨神经痛的治疗要么是保守的,如休息、固定、镇痛、抗炎,要么是手术治疗,这并不令人满意。本文报告了一例58岁的女性,她抱怨左下肢腰痛,左腿远端麻木,在没有支撑的情况下无法行走。basti cikitā(药物灌肠)是vāta do的pañcakarma(五种主要净化程序)中的主要治疗方式ṣa和śodhana疗法已经被证明比ś; amana、一种特定的śṛṃ哈ṇa(滋养组织和产生合成代谢作用)巴斯蒂是计划在这个特殊的情况下。研究中的病例在巴斯蒂治疗8天内和随访1个月后,几乎所有的主观和客观参数都有显著改善。347; odhana、347 amana和bṛṃ哈ṇa Basti在主观、客观和放射学参数方面都令人满意,在考虑do后可以应用于坐骨神经痛病例ṣ如涉及。
{"title":"Role of śodhana śamana and bṛṃhaṇa basti in the Management of gṛdhrasī","authors":"Adil Rais, S. Tanwar, A. Thakar","doi":"10.4103/asl.asl_213_16","DOIUrl":"https://doi.org/10.4103/asl.asl_213_16","url":null,"abstract":"gṛdhrasī is a common disorder explained in the context of vāta vyādhi in Ayurveda which greatly interferes with the quality of life. The symptoms of Gṛdhrasī simulate with sciatica. Sciatica is one of the most common causes of pain and disability. The treatment available in modern medicine for sciatica is either conservative such as rest, immobilization, analgesics, anti-inflammatory, or surgical which is not much satisfactory. Here, a case of 58-year-old female complaining of low backache radiating to the left lower limb along with numbness in the distal portion of the left leg and inability to walk without support, is reported. basti cikitsā (medicated enema) is the prime treatment modality among the pañcakarma (five main purifcation procedures) for vāta doṣa and śodhana therapy has already been established being better than śamana, a specific śodhana (purificatory), śamana (palliative) and bṛṃhaṇa (nourishing the tissues and producing anabolic effects) basti was planned in this particular case. The case under the study showed remarkable improvement in almost all the subjective and objective parameters within a span of 8 days of basti and after the follow-up of 1 month. śodhana, śamana, and bṛṃhaṇa Basti were satisfactory on subjective, objective as well as radiographic parameters and can be applied on cases of sciatica after consideration of the doṣas involved.","PeriodicalId":7805,"journal":{"name":"Ancient Science of Life","volume":"38 1","pages":"12 - 19"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41438284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ancient Science of Life
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1